Introduction
Most refinancings happen quietly. A company with $500 million of term loans coming due in 18 months hires its bookrunners, runs a refinancing process, prices a new facility at a slightly different rate, and the maturity moves out. The capital markets do the work; the restructuring banker is nowhere in the conversation. The maturity wall only matters when this routine breaks: when a specific issuer cannot access the market it needs at any acceptable cost. That break is when refinancing becomes restructuring, and it is one of the four primary triggers that pull RX bankers into a new engagement.
This article walks through the full topic: what a maturity wall actually is, the mechanics of the refinancing toolkit that scales most walls without restructuring (clean refinancings, amend-and-extend transactions, distressed exchange offers, liability management transactions), the structural reasons refinancing breaks down for specific issuers, the current 2026-2029 maturity profile across leveraged finance and commercial real estate, the timing implications for the bankers managing these situations, and a worked transition from "refi mandate" to "RX mandate."
What a Maturity Wall Actually Is
A maturity wall is the simplest distress trigger to describe. The company has debt principal due on a specific date; if the debt is not repaid, refinanced, or extended by that date, the company defaults. There is no judgment call about EBITDA add-backs or covenant cushion; the deadline is contractual.
- Maturity Wall
The aggregate principal amount of corporate debt maturing in a defined window, used either at the issuer level (the maturity wall facing one company) or at the market level (the maturity wall facing the leveraged loan or high-yield market in 2026-2027). At the issuer level, a maturity wall becomes a restructuring trigger when the company cannot refinance the maturing debt in the public or private capital markets at acceptable terms before the maturity date. At the market level, the wall describes the aggregate refinancing pressure that, even if absorbed in normal conditions, can create market-wide stress if a credit event or rate shock arrives at the wrong moment.
The reason the wall matters at the issuer level is that the markets that refinanced the original debt may not be open by the time it matures. A company that issued a high-yield bond at a 6% coupon in 2020 may face a market in 2026 that requires a 10% coupon for the same issuer, especially if the company's credit has deteriorated. If the company cannot service the debt at the new rate, refinancing is not a clean process; it becomes a restructuring negotiation in which the company asks holders to accept a lower coupon, a longer maturity, partial principal forgiveness, or equity in lieu of par.
The Refinancing Toolkit: Four Tools, Four Scenarios
When a company faces a maturity wall, the toolkit is bigger than just "refinance or restructure." Four distinct tools cover most situations, and the choice among them depends on credit health, time available, and the willingness of existing holders to participate.
| Tool | When To Use | Process Length | Required Consent | Cost / Concession |
|---|---|---|---|---|
| Clean refinancing | Credit healthy, market open | 6-12 weeks | None (existing debt repaid in full) | Higher coupon if rates have moved up |
| Amend-and-extend (A&E) | Credit OK but market would price wider, or relationships valuable | 4-8 weeks | Required-lender consent (often 50.1%); only extending lenders bound | Extension fee, modest margin step-up |
| Distressed exchange offer | Credit impaired, public bond holders | 30-60 days plus consent solicitation | Per-instrument minimum tender (often 95%+ for full unanimity, lower with exit consents) | New tranche with extended maturity, modified coupon, sometimes principal haircut |
| LMT or out-of-court restructuring | Credit materially impaired, capital structure too dispersed for clean exchange | 3-6 months | Majority class consent (priming) or unrestricted-sub mechanics | Subordination of non-participating creditors; equity conversion in some cases |
Tool 1: Clean Refinancing
The clean refinancing is the routine path. The company hires bookrunners (typically the same banks that arranged the existing debt), launches a new financing in the public or private market, and uses the proceeds to repay the maturing debt. The borrower's coupon resets to current market levels: the average yield-to-maturity on institutional term loan refinancings dropped from 9.6% in 2023 to 8.6% in 2024 to roughly 7.6% in 2025 as base rates eased and spreads tightened. The clean refinancing requires nothing from existing lenders other than receiving their principal back; nobody has to consent because nobody is being asked to extend or accept new terms.
Tool 2: Amend-and-Extend (A&E)
When market conditions or credit are not quite right for a clean refinancing, the next tool is the amend-and-extend. In an A&E, the borrower asks existing lenders to extend the maturity of their loans by two to four years in exchange for a fee, a margin step-up, and sometimes other concessions. The borrower's existing lender base moves out, the market does not have to clear a new deal, and the company avoids a refinancing event.
The A&E market did extraordinary work scaling the 2025-2027 leveraged loan wall. Total A&E volume in the US leveraged loan market reached $226 billion in 2024, eclipsing the 2023 record of $176 billion. In 2024 alone, sponsored and non-sponsored issuers extended $52.7 billion of loans originally maturing in 2026, $39.2 billion maturing in 2027, and $19.7 billion maturing in 2025. As a result, the loan volume maturing through end-2025 fell to $15.8 billion at the end of 2024 from $81.3 billion at the end of 2023, and leveraged loan maturities in 2026 and 2027 declined to roughly $59 billion as of December 2025 from $195 billion at the end of 2024.
Mandate (T-12 to T-18 months)
The borrower's CFO and treasurer engage the lead bookrunners (typically the existing administrative agents) to evaluate refinancing options. The bookrunners deliver an indicative term sheet covering coupon, fees, maturity, and required-lender consent levels.
Lender outreach (T-8 to T-12 weeks)
The arrangers reach out to the existing lender base on a no-names basis, gauging willingness to extend at proposed economic terms. Sponsor-owned credits often start with calls to the largest CLO managers and direct lenders that hold the bulk of the existing tranche.
Launch and consent solicitation (T-4 to T-8 weeks)
The borrower launches a formal A&E with a syndication memorandum. Existing lenders elect whether to extend (and accept new terms) or be repaid at maturity. Typical economics: 25-50 bps OID, a 50 bps extension fee at closing, sometimes an additional back-end fee, and a margin step-up of 25-75 bps.
Required-lender vote (T-2 to T-4 weeks)
If majority lenders consent, the amendment binds the entire tranche on covenant changes; only the lenders that elect to extend take the new maturity. Non-extending lenders are repaid at the original maturity, with the borrower bridging the takeout from new commitments or other liquidity.
Closing (T)
The amendment closes, the new maturity is in place, and the existing facility continues with the new terms.
A&Es typically clear at 51% lender consent on covenant changes, but only the lenders that affirmatively elect to extend take the longer maturity. This bifurcation matters because the borrower has to size the unmet maturity (the 2024 data showed roughly 75% of A&E activity was for issuers rated B-minus or higher; weaker credits had lower take-rates and required more aggressive bridge structures).
Tool 3: Distressed Exchange Offer
When the credit has deteriorated meaningfully but the company still has time and a willing creditor base, the distressed exchange offer (DEO) is the next tool. In a DEO, the company offers existing bondholders the chance to exchange their bonds for new bonds with different terms (typically extended maturity, modified coupon, sometimes a principal haircut, occasionally a senior position in the capital structure or new equity). DEOs are often combined with exit consents that strip non-participating bonds of restrictive covenants, which encourages participation by making the holdout position less attractive.
The structural challenge with DEOs in the US public bond market is the consent requirement: the Trust Indenture Act of 1939 requires unanimous bondholder consent to amend the principal amount, interest rate, or maturity of registered bonds. A DEO typically structures around this constraint by offering an exchange (which is voluntary) rather than amending the existing bond (which would require consent). The non-participating holders keep their original bonds (with the original maturity and coupon), but those bonds are typically structurally subordinated and stripped of covenants through the exit-consent mechanism, making the holdout position economically unattractive. DEOs scale meaningful capital-structure problems: a high-yield issuer with $1 billion of bonds maturing in 18 months and a deteriorating credit profile may run a DEO offering exchange into new five-year bonds at a higher coupon plus warrants. Participation rates of 90%+ are typical when the offer is well-structured; participation below 80% usually signals the offer was inadequate or that the market expects a cleaner path through a comprehensive restructuring or Chapter 11.
Tool 4: Liability Management Transaction or Comprehensive Restructuring
When credit is materially impaired and the capital structure is too complex or dispersed for a clean DEO, the company moves into LMT territory or a comprehensive out-of-court restructuring. The 2020-2025 LMT wave specifically targeted maturity-wall situations where the company could use unrestricted subsidiary baskets, available amount baskets, or other credit-agreement mechanics to issue new senior debt that primed existing debt, often providing maturity extension and new money in the same transaction. This is the territory where the maturity wall stops being a refinancing question and becomes a creditor-vs-creditor negotiation about who absorbs the haircut.
Why Refinancing Breaks Down for Specific Issuers
Most maturity walls get scaled because most issuers are healthy enough to access one of the four tools above. The wall becomes a restructuring trigger when refinancing breaks down for a specific issuer. Three structural reasons drive most cases:
- Credit deterioration. A company that issued debt at investment grade or low-tier high yield three years ago may have fallen to CCC by the time the debt matures. Capital markets do not reopen for CCC issuers without significant concession (much higher coupons, more restrictive covenants, additional collateral, equity warrants), and the concessions can make refinancing economically uneconomic compared to a restructuring.
- Sector dislocation. Even healthy issuers in distressed sectors face refinancing problems. Office REITs, regional malls, and certain consumer discretionary categories have seen capital markets effectively close to entire sub-sectors regardless of individual company performance. The 2026 office CMBS picture (Trepp's CMBS office delinquency rate reached an all-time high of 12.34% in January 2026 before easing to 11.4% the following month, with over $76 billion of CMBS facing hard maturity deadlines and over half of office CMBS maturities expected to default at maturity) shows how a sector-wide signal can override individual asset performance.
- Rate shock. A maturity that comes due during a sharp rate increase can become a restructuring even for solid credits. A company that issued debt at 5% and faces a refinancing at 9.5% may have coverage ratios that work at the original rate but not the new one. The 2022-2023 rate cycle pushed several issuers into this category, and the lagged effect continues to play out as floating-rate debt resets and fixed-rate maturities arrive.
Make-Whole Math and the Redeem-vs-Default Decision
For bond issuers approaching a maturity wall, the decision to refinance ahead of schedule is governed by the make-whole call provision in the indenture. The make-whole premium discounts the remaining scheduled cash flows at the matching-tenor Treasury rate plus a 50 basis-point spread, then floors at par:
where is the matching-tenor Treasury rate at redemption and the +50 bps spread is the market-standard make-whole formula. When prevailing rates have fallen since issuance, the discounted present value exceeds par and the issuer must pay a meaningful premium to redeem early; when rates have risen, the PV drops below par and the call simply pays par. Issuers approaching a wall use this calculation to decide whether to refinance ahead of schedule at a higher coupon plus the make-whole cost, or to ride the existing debt to maturity and refinance then. The strategic decision of redeem-versus-default lives inside this math: a company that cannot service the new coupon at any plausible refinancing rate, and cannot afford the make-whole to redeem cleanly, is functionally already in restructuring territory rather than refinancing territory.
The 2026 Commercial Real Estate Wall
Within the broader maturity-wall conversation, commercial real estate sits in a category of its own. Over $1.5 trillion of CRE loans will mature by the end of 2026, with the office sector facing the most acute pressure. Trepp's CMBS office delinquency rate reached an all-time high of 12.34% in January 2026 before easing to 11.4% the following month. More than $100 billion of CMBS loans mature in 2026, with over half expected to default at maturity.
Within CRE, the picture varies sharply by sub-sector:
- Office is in acute distress. The structural problem is not missed monthly payments (most office properties are still cash flowing through their existing leases) but maturity default: sponsors cannot refinance in a high-rate, low-occupancy environment because the new debt service either does not pencil or the lender will not underwrite the building at the prior valuation. The result is a wave of asset-level defaults that hit not as cash crises but as terminal refinancing failures.
- Multifamily is in a more manageable position. Maturities are large (multifamily CRE loan maturities jumped from approximately $104 billion in 2025 to roughly $162 billion in 2026, a 56% increase, with $167 billion scheduled for 2027), but CMBS-financed multifamily delinquency rates remained around 0.5% for loans due in 2026 as of late 2025. The sector's underlying cash flows have generally held up; the refinancing question is about structure (how to roll a 3.5%-coupon loan into a 6.5%-coupon environment) rather than fundamental property distress.
The 2026-2029 Leveraged Finance Maturity Profile
The leveraged finance maturity narrative has shifted across the cycle. The 2025-2027 wall, once described as a generational refinancing event, has been mostly digested by amend-and-extend and refinancing volume; the conversation is now about 2028-2029, where leveraged loan maturities are projected to climb above $300 billion in 2028 alone.
| Period | LevLoan maturing (Dec 2024) | LevLoan maturing (Dec 2025) | High-yield maturing |
|---|---|---|---|
| 2025 | $81.3B | $15.8B (refinanced) | Largely refinanced |
| 2026 | meaningful | substantially reduced (~$59B total 2026-2027) | Manageable, JPM projects $225B of 2026 HY refi activity |
| 2027 | meaningful | manageable | Approaching wall |
| 2028 | growing | rising sharply (~$301B) | Building |
| 2029 | distant | next focus area | ~$625B HY (Morningstar US HY index, 2027-2029 cumulative) |
The implication for restructuring practice is that the maturity-wall pipeline is real but more concentrated. Issuers that have already executed A&E or DEO transactions are buying time but typically at higher coupons that compress coverage ratios. The refinancings that did not happen in 2025-2026 (those issuers that the market judged uneconomic to refinance) are exactly the credits that show up on the RX banker's desk.
A Worked Transition: From Refi Mandate to RX Mandate
The cleanest way to see when refinancing becomes restructuring is to walk through one transition. Consider a hypothetical specialty retailer, sponsor-owned, with $1.2 billion of term loan B due September 2027, $400 million of senior unsecured notes due December 2027, and a $200 million ABL revolver due 2028. EBITDA has declined from $240 million at issuance to $160 million today, leverage has climbed from 5.5x to 9.0x, and the cov-lite term loan has not produced a covenant trigger but the high-yield bond market has effectively priced the company out at any rate the company can service.
The refinancing mandate (Q1 2026)
The company engages its existing bookrunners to refinance the term loan B, expecting to extend the maturity by three years at a rate consistent with the company's deteriorated credit. The bookrunners run a no-names market check, get back indicative pricing of 13-14% (well above what the company can service at current EBITDA), and recommend an A&E with the existing lender group at 11% with a 100 bps extension fee.
The A&E attempt (Q2 2026)
The arrangers approach the lender group. CLO managers holding 60% of the term loan are reluctant to extend at 11% on a credit where the leverage has nearly doubled. The borrower offers 100 bps OID and a 12% coupon. CLOs holding 35% commit to extend. Below-50% take-up means the A&E fails as proposed and the borrower has a $780 million unmet maturity in 18 months.
The transition to RX (Q3 2026)
The company hires a restructuring bank (the same firm that has been on the file as the M&A coverage advisor, now staffing the RX team alongside coverage). The first deliverable is a 13-week cash flow, but the alternatives memo focuses on the maturity wall: can a DEO be structured for the bonds and an LMT for the term loan, or does the company need to file a prepackaged Chapter 11?
The chosen path
The recovery analysis shows that an out-of-court LMT-plus-DEO can reduce funded debt from $1.6 billion to $1.0 billion with senior creditors taking new senior debt at a sustainable coupon and bondholders converting to a combination of new debt and equity. The company executes the transaction over six months, with a backup prepackaged Chapter 11 plan negotiated and held in reserve in case the consent thresholds are missed. The maturity wall is scaled, but the engagement that started as a routine refi mandate ended as a comprehensive restructuring.
What This Means for Restructuring Bankers
For a restructuring banker triaging a new mandate driven by a maturity wall, the workstream looks different from a covenant-breach engagement or a liquidity-crisis filing. The cash flow is usually fine for the moment; the company is not in imminent default; the negotiation is about whether and how to refinance, exchange, or restructure the maturing tranche before the deadline arrives.
The standard sequence is to map the cap stack, model the refinancing case (what coupon and structure would clear the market today), model the A&E case (what extension fees and consents are achievable), model the DEO case (what exchange terms would clear the bondholder group), and model the comprehensive restructuring case (what an LMT or prepackaged Chapter 11 would look like). The output is a recommendation that names the primary path and the fallback triggers. If the refinancing case is feasible, the banker often hands the deal off to the bank's coverage team or to a leveraged finance group; if the path runs through DEO or LMT, the engagement becomes a real restructuring with the full RX toolkit (13-week cash flow, recovery waterfall, strategic-decision memo) brought to bear.
The maturity wall is, in the end, an engineering problem for the leveraged finance market most of the time and a restructuring problem some of the time. The banker's job is to recognize which version they are looking at, and to do it early enough that the option set is still wide. Reframing a "refi mandate" into an "RX mandate" at the right moment is one of the most consequential judgment calls in coverage banking, and the moment usually arrives quietly: a single conversation with a CLO manager who declines to extend, a no-names indicative quote that comes back two hundred basis points wider than expected, or a single quarter of EBITDA that closes the door on the path the model assumed.
Free Interview PDF Guide